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Abstract
Background: Around 17% of people attending UK cardiac rehabilitation programmes have depression. Optimising
psychological wellbeing is a rehabilitation goal, but provision of psychological care is limited. We developed and
piloted an Enhanced Psychological Care (EPC) intervention embedded within cardiac rehabilitation, aiming to test key
areas of uncertainty to inform the design of a definitive randomised controlled trial (RCT) and economic evaluation.
Methods: An external pilot randomised controlled trial (RCT) randomised eight cardiac rehabilitation teams (clusters) to
either usual care of cardiac rehabilitation provision (UC), or EPC in addition to UC. EPC comprised mental health care
coordination and patient-led behavioural activation with nurse support. Adults eligible for cardiac rehabilitation following
an acute coronary syndrome and identified with new-onset depressive symptoms during an initial nurse assessment
were eligible. Measures were performed at baseline and 5- and 8-month follow-ups and compared between EPC and
UC. Team and participant recruitment and retention rates, and participant outcomes (clinical events, depression, anxiety,
health-related quality of life, patient experiences, and resource use) were assessed.
Results: Eight out of twenty teams were recruited and randomised. Of 614 patients screened, 55 were eligible and 29
took part (5%, 95% CI 3 to 7% of those screened), with 15 patient participants cluster randomised to EPC and 14 to UC.
Nurse records revealed that 8/15 participants received the maximum number of EPC sessions offered; and 4/15 received
no sessions. Seven out of fifteen EPC participants were referred to another NHS psychological service compared to none
in UC. We followed up 27/29 participants at 5 months and 17/21 at 8 months. The mean difference (EPC minus UC) in
depressive symptoms (Beck Depression Inventory) at follow-up (adjusting for baseline score) was 1.7 (95% CI − 3.8 to 7.3;
N = 26) at 5 months and 4.4 (95% CI − 1.4 to 10.2; N = 17) at 8 months.
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Discussion: While valued by patients and nurses, organisational and workload constraints are significant barriers to EPC
implementation. There remains a need to develop and test new models of psychological care within cardiac
rehabilitation. Our study offers important data to inform the design of future trials of similar interventions.
Trial registration: ISRCTN34701576. Registered on 29 May 2014.
Funding details: UK NIHR HTA Programme (project 12/189/09).
Keywords: Depression, Coronary heart disease, Multimorbidity, Behavioural activation, Mental health care coordination,
Cardiac rehabilitation, Randomised controlled trial, Qualitative interviews,
Background
Depression is common in people with coronary heart dis-
ease (CHD), affecting approximately a fifth of individuals
following an acute coronary syndrome (ACS) [1], coronary
artery bypass grafting (CABG) [2] and chronic heart fail-
ure [3]. Such depression is important as it is associated
with worse health-related quality of life [4–6], greater use
of unscheduled care [7, 8], increased health care costs [9]
and a doubling of risk of subsequent morbidity and mor-
tality [10–14]. The detection and appropriate manage-
ment of depression among people with CHD is a policy
priority in the UK and in many other countries with well-
developed health care systems [15–18].
For most people in the UK who have experienced an
ACS or have had coronary revascularisation, cardiac
rehabilitation is offered by the National Health Service
(NHS) as part of routine care to help people return to
optimal functioning. This rehabilitation usually incor-
porates education, exercise and psychological support,
although the exact form of the psychological support
provided is not well defined in guidance documents
[19] and remains open to interpretation by individual
services. While psychological treatments, such as cog-
nitive behavioural therapy, for example, are effective
for depression in people with CHD [20, 21], very few
rehabilitation services provide access specific psycho-
logical treatments part of cardiac rehabilitation. Fur-
thermore, only a minority of rehabilitation services
(18% in 2014) provide direct access to specialist psy-
chological care [1]. Thus, despite the availability of
evidence-based interventions in primary and secondary
care, the majority of people attending cardiac rehabili-
tation in the UK do not receive adequate treatment for
depression.
To improve access to evidence-based psychological
treatment for depression among people attending cardiac
rehabilitation, we developed and conducted a preliminary
evaluation of a complex intervention (Enhanced Psycho-
logical Care or ‘EPC’) for delivery by cardiac rehabilitation
nurses alongside routine cardiac rehabilitation. Our aim
was to pilot the methods and procedures required to
undertake a fully powered evaluation of the clinical effect-
iveness and cost-effectiveness of implementing EPC for
patients with new-onset depressive symptoms using car-
diac rehabilitation compared with treatment as usual [22].
This paper reports on three specific objectives: to docu-
ment the flow of patients through a pilot trial (i.e. study
eligibility, recruitment and attrition rates); collect partici-
pant outcome data to support sample size calculations for
a definitive trial; and to establish the optimal data collec-
tion methods required to support an economic evaluation.
We also undertook qualitative interviews with patients
and nurses recruited into the study to explore their views
on the acceptability of EPC and of our study procedures.
The methods and results of these interviews have been re-
ported elsewhere [23].
Methods
The full methods employed in the CADENCE study are
described in a protocol paper [22].
Study design
An external pilot cluster randomised controlled trial
(RCT) [24, 25], including the piloting of economic data
collection, was undertaken. We sought to recruit and
randomise eight teams (clusters) delivering a compre-
hensive cardiac rehabilitation programme to either the
intervention (EPC) or control (usual care (UC)) arms in
a 5:3 ratio. This randomisation ratio was used to ensure
that sufficient nurses and patients were exposed to EPC
to support the aims of the qualitative interview study.
Randomisation was carried out by the trial statistician
(FW) who was independent of the recruitment of rehabili-
tation teams and patient participants. The allocation se-
quence was determined using computer-generated random
numbers. Cluster randomisation was balanced by team
type (community, hospital or mixed community and hos-
pital teams) and patient throughput at the initial cardiac
rehabilitation assessment (‘low’ ≤ 22 patients per month vs
‘high’ > 22 patients per month), the latter facilitating div-
ision into small and large teams. The cluster randomised
design was essential to avoid contamination between trial
arms (for example, it was deemed unrealistic that nurses
trained in mental health care coordination would be ex-
pected to offer this management approach only to inter-
vention group participants and not those in the control
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arm). To conceal the allocation sequence from cardiac
teams, the cluster randomisation took place immediately
after the last team was recruited.
Interventions tested
Usual care (controls)
Usual care was defined as cardiac rehabilitation, com-
mencing at the point the patient attended a specialist
cardiac rehabilitation nurse assessment clinic prior to
starting a structured rehabilitation programme. The UK
British Association of Cardiovascular Prevention and Re-
habilitation (BACPR) publish core standards regarding
the content of structured rehabilitation, which is com-
monly delivered in one or two sessions per week for ap-
proximately 8 weeks. Sessions last around 2 h and
include structured exercise and education (e.g. managing
cardiac risk factors) and psychological input (e.g. stress
management and/or relaxation training). The 2012
BACPR standards [26] were in effect during this trial
(new standards came into effect in 2017 [27]). The 2012
standards advocated the provision of psychosocial care
and routine monitoring of mood (anxiety and depres-
sion) upon referral and discharge. However, detailed
guidance on how psychosocial care should be delivered
is not provided. National audit data reports that psycho-
logical expertise within cardiac rehabilitation teams is
uncommon (< 15%) [1]. Informal discussions with men-
tal health specialists and cardiac rehabilitation staff sug-
gest that there is considerable variation in local cardiac
team protocols across the UK, with specialist referrals to
mental health services frequently resulting from clinical
observation and intuition.
EPC (treatment)
A detailed description of the development of our EPC
intervention [28], and of the rationale and content sup-
porting its design is reported elsewhere [29]. Briefly, EPC
was designed to be embedded within the existing cardiac
rehabilitation care pathway and delivered by cardiac nurse
specialists supported by an intervention manual. EPC con-
sisted of mental health care coordination [30, 31], includ-
ing an embedded participant-led behavioural activation
(BA) programme [32–37] designed to tackle depressive
symptoms. Nurses were trained to apply best-practice
clinical decision-making rules [30, 31], matching the in-
tensity of treatment with participant preferences for men-
tal health care. Nurses were also supplied with a manual
to support intervention delivery.
The nurse explained the evidence-based treatment op-
tions available to all potentially eligible patients. This in-
cluded BA self-help materials supported by the nurse as
part of the cardiac rehabilitation programme, and/or re-
ferrals to their general practitioner (GP), local mental
health services, or referral to specific cardiac patient
psychological support services where available. Nurses
were trained to coordinate care while the participant
attended cardiac rehabilitation by monitoring depressive
symptoms, assessing risk to self or others and agreeing/
reviewing any changes to the mental health care plan
with participants, including onward referral to other
services.
All participants were also offered nurse-supported self-
help using a participant BA handbook. The handbook
consisted of a structured programme designed to support
participants in re-engaging with sources of positive
reinforcement from their environment and to develop fu-
ture strategies for managing their depressive symptoms. A
functional analytical approach was adopted, with the
handbook designed to help participants develop an under-
standing of behaviours that interfere with meaningful,
goal-oriented behaviours. By teaching the participant to
self-monitor mood, individuals were shown how to iden-
tify patterns of behaviour associated with their depression.
Participants were then encouraged to develop alternative
behaviours which were goal-orientated, targeting routine,
pleasurable and necessary activities and using diaries to
plan these behaviours into daily schedules.
Although our pilot intervention involved a participant-
led, self-help BA handbook, nurses were trained to actively
support participants. A 2-day training course was deliv-
ered by experienced mental health practitioners, during
which nurses were trained in key techniques of mental
health care coordination, managing safety and risks, and
BA. Supported by an intervention manual, nurses were
also provided with a session by session guide, detailing the
types of coordination actives required as participants
moved through their 6–8-week cardiac rehabilitation
programme (Additional file 1: Table S1). This guide was
flexible to accommodate participant preferences for care.
Nurses delivering EPC to participants also received bi-
weekly clinical supervision by an experienced mental
health practitioner over the telephone.
On completion of their cardiac rehabilitation programme,
nurses were required to send structured details of the
mental health care that they had delivered to the participant
to the participant’s GP. All participants, including those re-
ceiving BA and whose depressive symptoms do not re-
spond, were given an opportunity to review their
management options with the nurse. Here, treatment re-
sponse was defined as achieving a minimally clinical im-
portant difference (MCID) for the Patient Health
Questionnaire-9 (PHQ-9) equivalent to a 5-point reduction
in score [38]. It was expected that some people who
achieved this MCID remained above the PHQ-9 diagnostic
threshold (≥ 10) for depression; as part of their care coord-
ination, these individuals were referred for continuing men-
tal health management upon discharge from cardiac
rehabilitation services.
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Settings and study population
We aimed to recruit and randomise eight cardiac re-
habilitation teams. We wrote to the lead nurse in each
of the 20 operationally distinct teams in South West
England, providing detailed information about the study
and inviting participation. Each team expressing an
interest received a briefing visit, where the trial design
and methods were explained by a researcher, and the
staff were given an opportunity to ask questions before
being asked to provide written consent to participate.
All teams agreeing to participate received training in
study procedures. Nurses in teams allocated to the EPC
intervention arm received EPC training before partici-
pant recruitment began.
Participant eligibility criteria
Nurses were trained to apply a structured checklist to
ascertain participant eligibility. All adult patients (aged
18 years or over) referred for cardiac rehabilitation based
on local clinical referral protocols were screened for eli-
gibility. The sample comprised individuals previously ad-
mitted with an acute coronary syndrome (unstable
angina, non-ST-elevation myocardial infarction (MI) or
ST-elevation MI) and/or following a coronary revascu-
larisation procedure (percutaneous coronary interven-
tion (PCI), CABG), with or without heart failure [1].
Patients were routinely screened for depressive symp-
toms using the nine-item Patient Health Questionnaire
(PHQ-9) [39, 40], with individuals scoring 10 or more
deemed potentially eligible for inclusion. Patients were
excluded if they reported active treatment for depression
(psychological or drug therapy) within the previous 6
months. Individuals were also excluded where there was
evidence of alcohol or drug dependency, active suicidal
intention or having poorly controlled bipolar disorder or
psychosis/psychotic symptoms based on a clinical re-
view. Although no language exclusions were applied, we
anticipated that the majority of patients would require
sufficiently good English language skills to engage with
the manual-based EPC intervention, with NHS transla-
tion services employed if needed.
Patient participant recruitment procedure
Eligible participants were invited to take part by a nurse
during their initial clinic appointment (prior to com-
mencing a structured rehabilitation programme), and
given a brief study sheet to take away and review. The
nurse also gained permission to pass the individual’s
contact details on to the research team. A researcher
then contacted the patient within 7 days to discuss par-
ticipation and provide them with a detailed Participant
Information Sheet. The researcher arranged a visit to
obtain written consent and to undertake the baseline
trial assessment before the participant commenced the
structured rehabilitation programme. Participants were
informed that trial participation was voluntary, and that
they could withdraw from the study at any time without
reason, and that withdrawing would not affect their on-
going clinical care in any way.
Sample size
Using UK national audit data (2010–2011), 55,452 pa-
tients (for MI, PCI, CABG) engaged in cardiac rehabili-
tation with one of 280 teams (an average of 200 patients
per team per year). Assuming that 17% had depressive
symptoms [27], this equated to 35 eligible patients per
team each year. Establishing participant eligibility and
consent rates were key goals of this pilot study as there
was no applicable UK data employing a cluster RCT de-
sign. For planning purposes we assumed a participation
rate of 50%, aiming to recruit 64 patients through the
eight teams in 6 months; this target was subsequently
amended to 47 participants on completion of a feasibility
study (which preceded the pilot trial), which identified
that unless the participant recruitment period was ex-
tended beyond 6 months, we would be unlikely to
achieve our initial target (full details are described else-
where [29]). This sample size is sufficient to estimate a
follow-up percentage as low as 50% with margin of error
± 15% based on the width of the 95% confidence interval
(CI), and as high as 90% with a margin of error of ± 13%
based on the lower bound of the 95% CI. We did not es-
timate the intra-cluster (intra-CR team) correlation coef-
ficients (ICC) for key outcomes as the pilot sample was
small and estimates would have been imprecise. Using
national audit data available during the planning phases
of this research (2010–2011; 6272 patients; 119 cardiac
rehabilitation teams), we estimated the ICC for depres-
sion measured using the Hospital Anxiety and Depres-
sion Scale [41] to be 0.047 (95% CI, 0.034 to 0.062). This
ICC estimate and CI were used to inform the sample
size calculations for the definitive trial.
Data collection
All participants were assessed by a researcher complet-
ing measurements on up to three occasions. Baseline
measures were completed prior to commencing car-
diac rehabilitation, and then two follow-up interviews
were scheduled at 5 and 8 months post randomisation
(Fig. 1). A summary of the measures collected at each
time point can be found in Additional file 1: Table S2.
Blinding of patients, practitioners or researchers
extracting data on study outcomes was not possible in
this cluster design, but the final analysis was carried
out by a statistician who was blind to treatment alloca-
tion. Data were collected on process measures, patient
outcomes, and resource use and costs.
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Fig. 1 Consolidated Standards of Reporting Trials (CONSORT) Diagram. CONSORT Diagram (with cluster extension) for the CADENCE pilot randomised
controlled trial (RCT)
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Process measures
Process data on study eligibility and participant recruit-
ment were collected by nurses. We extracted data on
the number of patients attending an initial nurse assess-
ment, the proportion identified with depressive symp-
toms during this assessment, the prevalence of new-
onset (as opposed to recently treated) depression and
the number of patients deemed eligible for trial partici-
pation. For eligible patients, we documented the num-
bers: offered study entry; agreeing to be contacted by a
researcher; and those subsequently consenting to take
part and undergoing a baseline interview. Participant
socio-demographic characteristics (age, sex, Index of
Multiple Deprivation (IMD) score [42], ethnicity/pre-
ferred language) and underlying cardiac condition were
also collected. The proportion of participants completing
follow-ups at 5 months (primary endpoint) and 8
months was also reported.
Intervention fidelity was assessed through a review of
nurse clinical records. We extracted data on the number
of cardiac rehabilitation sessions attended by each par-
ticipant and the proportion where there was documen-
tary evidence of mental health care coordination in their
notes and the type of psychological referrals made
(where appropriate). For participants in the EPC arm we
also assessed intervention adherence by recording the
number of cardiac rehabilitation sessions attended and
where the BA component of EPC was reviewed.
Participant outcomes measures
Baseline assessment only Although not determining
study eligibility, the Revised Clinical Interview Schedule
(CIS-R) [43, 44] was administered for the purposes of re-
search to ascertain a clinical diagnosis of depression and
other disorders. Participants were also asked for their
treatment preferences [45] prior to commencing re-
habilitation. Data from clinical records (GP and cardiac
nurse notes) were extracted regarding known cardiac
risk factors (Body Mass Index (BMI), blood pressure,
glycosylated hemoglobin (HbA1c), lipids, smoking sta-
tus) as recorded at the participant’s latest clinical assess-
ment prior to recruitment.
Baseline and follow-up measures We requested that
NHS providers inform us of any participant deaths be-
tween baseline and the 8-month follow-up. At the last
follow-up we also recorded the date and last recorded
known cardiac risk factors in nurse notes. At the same
time, we contacted the participant’s GP to arrange for a
researcher to extract relevant data from primary care re-
cords, including the incidence of any new cardiac events,
i.e. death and/or hospital admissions for acute coronary
syndromes or revascularisation procedures (CABG or
PCI), or mental health events (e.g. self-harm, suicidality)
arising since study enrolment. In addition to being out-
comes, these were part of the safety monitoring of ser-
ious adverse events (SAEs) and adverse events (AE)
within the trial.
The baseline and follow-up interviews included
participant-reported cardiac-related and non-cardiac-
related morbidity and smoking status, antidepressant
medication use [46], and resource use. Cardiac nurses
used the PHQ-9 to identify and monitor depressive
symptoms as part of clinical care. As patients in the EPC
arm were likely to complete this tool more often than
those in UC, this might differentially impact on its scor-
ing independent of any treatment effects, as EPC partici-
pants become familiarised with it. Thus, for the
purposes of research, depressive symptom severity was
measured using the Beck Depression Inventory (BDI-II)
[47, 48] (range 0–63), with minimal (0–13), mild (14–
19), moderate (20–28) and severe (29–63) symptom se-
verity ranges specified.
The Beck Anxiety Inventory (BAI) [49, 50] was
assessed as anxiety is commonly comorbid with depres-
sion. Item scores are summed with total scores of 8–15,
16–25 and 26–63 taken as ranges defining categories for
mild, moderate or severe anxiety, respectively. Health-
related quality of life (HRQL) was quantified using both
generic and disease-specific measures. The EuroQoL
Index (EQ-5D-5 L) [51, 52] is a standardised generic
HRQL measure commonly used for economic evalua-
tions alongside clinical trials. The HeartQoL question-
naire [53, 54] is a disease-specific measure comprising
14 items covering physical and emotional domains. For
both tools lower scores representing poorer HRQL.
To assess patient activation over the course of their
EPC, we administered the nine-item Behavioral Activa-
tion for Depression Scale – Short Form (BADS-SF) [55],
with scores ranging from 0 to 54 and high scores repre-
senting greater activation.
Participant experiences of care were assessed at the 5-
month follow-up using the self-reported Client Satisfac-
tion Questionnaire (CSQ-8) [56] and an adapted version
of the NHS Friends and Family Test (FFT). The CSQ-8
is composed of eight items with scores ranging from 8
to 32 with higher values indicating greater satisfaction.
The FFT asks whether you would recommend the care
received to family and friends, and includes a single item
with a 5-point rating scale (‘Extremely likely’ to ‘Ex-
tremely unlikely’) and two free-text items (‘What was
good about your experience?’; and ‘What would have
made your experience better?’).
Economic evaluation
We adopted a societal perspective as this is the analytic
approach recommended by the UK National Institute
for Clinical Excellence. We tested the methods of
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resource and service-use data collection to enable esti-
mation of the costs to the NHS, costs to social care and
personal social services, and relevant costs to patients
and their carers/families (including NHS and privately
funded mental health care). A preliminary assessment of
the cost of providing EPC within cardiac rehabilitation
was undertaken. Service-use data were extracted by re-
searchers from routine/administrative sources (e.g. car-
diac nurse records, GP records) and participant self-
report using the Service and Resource Use Question-
naire (SRUQ). The SRUQ was adapted from the Client
Services Receipt Inventory [57], with input from our lay
advisors. The completeness and reliability of participant
reporting was compared with routine administrative data
for the types/amounts of health care/service used over
the follow-up periods.
Statistical analysis plan
As this is a pilot study we do not report definitive esti-
mates of effectiveness and costs. Pilot study data were re-
ported according to the Consolidated Standards of
Reporting Trials (CONSORT) extension for cluster rando-
mised trials [58]. Recruitment, intervention and control
uptake, outcome completion rates and dropout rates were
reported with 95% CIs. Recruitment rates and participant
characteristics at baseline were compared between the
trial arms to assess whether there was evidence of selec-
tion bias resulting from cluster randomisation which took
part prior to participant recruitment [59].
Baseline characteristics of the participants were sum-
marised by trial arm status using means and standard
deviations (SDs) (or medians and interquartile ranges)
for continuous variables, and numbers and percentages
for categorical variables. Participant-reported outcomes
were compared between trial arms (i.e. EPC minus UC),
adjusting for baseline scores, using linear regression for
continuous variables and logistic regression for binary
variables based on an intention-to-treat analysis. As this
is a pilot study we reported only 95% CIs and no p
values. We did not use analytical methods that allow for
clustering because the number of clusters and partici-
pants per cluster was too small. For this reason, and the
fact that this is a pilot study, the CIs should be inter-
preted cautiously. We carried out a complete case ana-
lysis, including only those participants who provided
outcome data. No data were imputed as this is not a de-
finitive trial of intervention effectiveness.
In addition, as part of piloting the BDI-II, treatment
effects regarding depression symptom severity were re-
ported in five ways: (1) mean (SD) and between-group
mean difference; (2) the proportion of participants dem-
onstrating a reduction in score from baseline by > 50%
(deemed a clinically important ‘response’ to treatment
[60]); (3) the proportion of participants demonstrating
remission (going from scores ≥ 14 to < 14); (4) the pro-
portion of participants demonstrating a minimal clinic-
ally important difference (MCID) in the BDI-II scores of
17.5%; [61] and (5) a clinically significant and reliable
change (CSRC), where participants meet two criteria: (a)
passing below the BDI-II remission threshold (see (3)
above) and (b) establishing that the magnitude of the
participant’s change in score is statistically reliable, i.e.
the difference between the participant’s scores at base-
line and follow-up was calibrated by the standard error
of the difference between two scores [62]. All statistical
analysis was undertaken in Stata v14.
Ethical and governance considerations
The Royal Devon and Exeter NHS Foundation Trust
acted as the trial sponsor. The CADENCE study proto-
col (version 4, 19 June 2015), was reviewed and received
a favourable ethical opinion from the NHS National Re-
search Ethics Service Committee South West – Exeter
(reference: 14/SW/0139) and the relevant NHS research
governance approvals were obtained. All nurse and pa-
tient participants provided written consent prior to par-
ticipating in this study.
This study is registered with the IRCTN trials registry
(ISRCTN34701576) and was adopted by the UK Com-
prehensive Research Network (UKCRN ID: 17105). All
researchers and nurses involved in participant recruit-
ment undertook Good Clinical Practice (GCP) training.
Patient and public involvement
Patient and public involvement (PPI) was sought during
protocol development following a published framework
for PPI involvement in research [63]. Four lay advisors
with relevant lived experience, reviewed and commented
on our research proposal. PPI continued throughout the
project, with the precise roles of advisors negotiated
across time. In the early stages, our advisors reviewed
outcome measures and informed the design of all study-
related materials, including Participant Information
Sheets and the development of intervention manuals.
Lay advisors also attended project management meetings
on a quarterly basis and actively participated in decisions
related to the ongoing running of the project; for ex-
ample, advising on the acceptability to patients of modi-
fications to EPC intervention.
Results
Recruitment
The recruitment and flow of cardiac teams and patient
participants are summarised in Fig. 1. Between Decem-
ber 2014 and February 2015, 20 cardiac rehabilitation
teams were approached, of which eight agreed to partici-
pate (40%), nine declined, two did not respond and one
ceased to exist due to service reconfiguration. Teams
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were then randomised (five to EPC and three to usual
care (UC)), with one team withdrawing from the EPC
arm immediately post randomisation. This team was re-
placed with another team recruited from the West Mid-
lands that was similar with respect to patient throughput
and population mix.
Of the eight participating teams, two were hospital
based, three were community based and the remainder
based both in the community and at the hospital (Table 1).
Team size and throughput varied considerably, with teams
comprised of between one and seven cardiac nurses work-
ing either part-time or full-time, and providing care for be-
tween 12 and 70 patients per month. Most of the teams
offered centre-based programmes either in the community
and/or at the hospital, clinic-based individual appoint-
ments and home-based programmes with one team offer-
ing only centre-based programmes. The majority of teams
were in urban and rural settings, with only two teams serv-
ing inner-city patient populations. The three UC teams
had no access to psychological support integrated within
their cardiac rehabilitation programme, although one team
reported having limited access to a clinical psychologist.
Three of the EPC teams had little or no access to psycho-
logical support; the other two EPC teams, located in inner
city areas, had established close links to the clinical psych-
ology and community mental health services.
Due to unforeseen delays in securing regulatory ap-
provals in some areas, individual teams recruited pa-
tients for between 3 and 6 months during the period
June 2015 to December 2015. A total of 614 patients
(389 EPC arm, 225 UC arm) were screened for eligibility,
of whom the mean age was 66.2 years (range 32 to 95
years), 70.2% were male (481/614) and 94.3% reported
their ethnicity as ‘White’ (579/614). Eighty-nine out of
614 (14.5%) scored 10 or more on the PHQ-9, of whom
55/614 were deemed eligible for the trial (9%, 95% CI 7%
to 12%); 33 were ineligible as they were either actively
being treated for depression (n = 21, 3% 95 CI 2% to 5%)
, or excluded for other reasons (e.g. alcohol and/or drug
dependency problems, were currently ineligible for car-
diac rehabilitation based on their cardiac condition, or
had language and communication problems).
Fifty-one of the 55 patients deemed to be eligible by a
nurse were invited to participate. Of the four patients
not invited, one patient declined any further input from
the cardiac rehabilitation service, two patients were not
offered EPC as the nurse was at capacity and could not
take on more patients, and the final patient reported a
marked improvement in mood and did not feel that they
required EPC. Of the 51 patients offered study entry, 21
declined participation (41%) for a variety of reasons in-
cluding: a preference to see their GP (n = 6); feeling bet-
ter and would prefer to see how mood goes while taking
part in cardiac rehabilitation (n = 3); that their mood
was a long-standing problem unrelated to this current
hospital stay (n = 2); or they did not want the EPC inter-
vention (n = 2) (nine patients did not give a reason).
Thus, of the 55 eligible patients, 30 (54%, 95% CI 41 to
Table 1 Characteristics of participating sites at baseline
Team Allocation Team location
(setting)
Cardiac team clinical staffing Type of cardiac rehabilitation programme offered
(including usual psychological carea)
N patients assessed
per monthb
A UC Hospital (rural) 7 nurses (2 full-time;
5 part-time)
Centre-based groups, Clinic-based individual
appointments, Home-based programmes
40
B UC Community (rural) 7 nurses (1 full-time;
6 part-time)
Centre-based groups – with some support from
a clinical psychologist, Clinic-based individual
appointments, Home-based programmes
60
C UC Community (rural) 3 nurses (part-time), 1 team
manager (part-time)
Centre-based groups 12–16
D EPC Community (rural/
urban)
2 nurses (1 full-time;
1 part-time)
Centre-based groups, Clinic-based individual
appointments, Home-based programmes
26
E EPC Hospital (rural/urban) 2 nurses (part-time) Centre-based groups, Clinic-based individual
appointments, Home-based programmes
70
F EPC Mixed hospital +
community (urban)
1 nurse (part-time) Centre-based groups, Clinic-based individual
appointments, Home-based programmes
32
G EPC Mixed hospital +
community (inner-city)
4 nurses (part-time) Centre-based groups – limited psychological
input via referral to community mental health
workers, Clinic-based individual appointments,
Home-based programmes
33
H EPC Mixed hospital +
community (inner-city)
6 nurses (part-time) Centre-based groups, Clinic-based individual
appointments – part-time clinical psychologist
linked to team, Home-based programmes
50–60
EPC Enhanced Psychological Care, UC usual care
aUnless stated there is no dedicated psychological support available (either within the team, or through an established referral pathway)
bData derived from the team profile questionnaire completed prior to randomisation. Teams reported the ‘average’ number of patients assessed per month
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68%) were initially recruited (one of whom withdrew
prior to providing baseline data) and 29 participants
were effectively (cluster) randomised (15 EPC; 14 UC),
equivalent to 5% (95% CI 3 to 7%) of the 614 patients
screened.
At the 5-month follow-up 27/29 participants com-
pleted an assessment (93%, 95% CI 77 to 99%). At 8
months we were unable to collect data for 8/29 partici-
pants, due to slower than anticipated recruitment to the
trial such that these participants could only contribute
data to the 5-month follow-up before data collection
closed due to funding constraints. Of the 21 participants
for whom 8-month data could have been obtained, 17
(81%, 95% CI 58 to 95%) provided data.
Sample characteristics
Of the 51 eligible participants who were offered study
entry, 15/29 (52%) male patients and 15/22 (68%) female
patients accepted. Of 49 eligible White patients invited
to participate, 19 declined (39%), as did both of the two
Asian/Asian British patients. The mean age among 30
eligible patients who accepted participation was 63.8
years (SD 9.5), range 47 to 78 years; among 21 patients
who declined, mean age was 61.1 years (SD 12.3), range
36 to 83 years. For the acceptors, mean PHQ-9 score
was 13.4 (SD 4.1), range 10 to 25; for the decliners,
mean PHQ-9 score was 14.4 (SD 4.6), range 10 to 24.
The socio-demographic characteristics, smoking sta-
tus, and health status of trial participants are reported in
Table 2. While both trial arms were broadly similar
across a range of baseline characteristics, there was
some imbalance, with the EPC arm having a greater pro-
portion of participants in the three most deprived deciles
compared with UC (40% (6/15) versus 14% (2/14)). Des-
pite recruiting in some ethnically diverse areas, all par-
ticipants reported their ethnicity to be White. Some
imbalance was also observed regarding baseline health
characteristics. The EPC group reported higher levels of
depression at baseline compared with UC (mean PHQ-9
score 14.2 versus 11.9) and BDI-II (18.4 versus 12.5);
67% (10/15) participants in EPC had a BDI-II score of ≥
14 compared with 50% (7/14) in UC.
The precipitating cardiac events as recorded in GP or
cardiac nurse records at baseline are reported in Table 2.
The majority of patients attended cardiac rehabilitation
following an acute coronary syndrome and/or revascu-
larisation, and these were equally distributed between
the two groups.
EPC delivery
Seven nurses from four teams provided EPC to one or
more participants (one team recruited no participants to
the study). Three teams had two nurses providing EPC
and one team had a single practitioner. Most nurses had
their own participants allocated to them, occasionally
sharing cases when the allocated nurse was unavailable.
Thirty clinical supervision calls were made to the teams
over a 7-month period.
The number of cardiac rehabilitation sessions attended
recorded in nurse notes ranged from 0 to 22 (mean 8.3,
SD 8.1) for EPC participants and 1 to 12 (mean 7.4, SD
2.7) in UC (Table 3). Consistent with the training pro-
vided, there was documentary evidence that a maximum
of eight sessions of EPC were offered. Approximately
half received the maximum number of sessions (8/15,
53%), while 4/15 (27%) of participants had no EPC ses-
sions recorded (Table 3). Documentary evidence of men-
tal health care coordination activities was observed for
47% (7/15) of EPC participants referred on to another
NHS service (e.g. GP or another psychological care ser-
vice). This compared with 0/14 (0%) of UC participants.
No participants in either arm self-reported accessing pri-
vate mental health care.
Clinical outcomes
No deaths were recorded in either arm of the trial be-
tween baseline and the final follow-up. Eight new cardiac
events/diagnoses were recorded between baseline and
the 5-month follow-up period and a further four events
occurred between 5 months and 8 months (Table 4).
Between baseline and the 5-month follow-up only two
participants (one EPC, one UC) had evidence of a men-
tal health event related to a newly diagnosed condition
recorded in GP records, and two participants (one EPC,
one UC) had evidence of prescribing antidepressant
medication.
To test the feasibility of collecting physiological and
biochemical measurements from routine records, we
assessed data availability from either GP or cardiac nurse
records. The routine recording of such measurements
was highly variable (Additional file 1: Table S3); blood
pressure measurements were the most frequently re-
ported, with other measures (HbA1c and triglycerides)
frequently omitted.
During the trial, the protocol relating to managing
self-harm/suicide risk was triggered for three partici-
pants. Three of these were recorded by the nurse during
an EPC intervention session and one managed by a re-
searcher during an assessment. For each participant, the
initial risk was identified as the individual reporting
plans/preparations to self-harm but with protective fac-
tors identified, and the individual advised to seek help
from their GP. One participant was subsequently esca-
lated to a higher risk as they had taken no action to talk
to their GP regarding their mood, and their GP was con-
tacted (with the participant’s permission) to alert them
to the risk.
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Eleven serious adverse events relating to six partici-
pants were recorded, including participant admissions to
hospital on account of infective conditions, asthma or
cardiac complications (e.g. chest pain, additional stent
requirement, postural hypotension). None were judged
to be related to the trial intervention or research proce-
dures by an independent monitoring committee.
Participant-reported outcome measures
Participant-reported outcomes reported at 5- and 8-
month follow-up are presented in Table 5. In terms of
depressive symptoms, the mean difference (EPC minus
UC) in BDI-II score at follow-up (with adjustment for
Table 2 Participant characteristics at baseline
UC, N = 14 EPC, N = 15
Gender; n (%)
Male 7 (50) 8 (53)
Age (years); mean (SD) 68.1 (8.6) 62.7 (8.9)
Ethnicity; n (%)
White 14 (100) 15 (100)
Preferred language; n (%)
English 13 (93) 15 (100)
Other 1 (7) 0 (0)
Smoking status; n (%)
Never smoked 5 (36) 4 (27)
Ex-smoker 9 (64) 11 (73)
Time since quitting smoking
(ex-smokers only); n (%)
Less than 6 months 3 (33) 3 (27)
6 to 12 months 0 (0) 0 (0)
1 to 5 years 0 (0) 2 (18)
5 to 10 years 1 (11) 0 (0)
More than 10 years 5 (56) 6 (55)
Index of Multiple Deprivation
median decile (IQR) (lower
deciles are more deprived)
6 (4, 8) 5 (1, 7)
Index cardiac event and/or
and proceduresa
ACS and/or revascularisation 11 (79) 11 (73)
Other heart conditionb 3 (21) 1 (7)
Other cardiac procedure
(pacemaker, valve surgery)
0 (0) 3 (20)
CIS-R primary diagnosis
category; n (%)
N = 13c N = 14c
No psychiatric diagnosis
identified
9 (69) 6 (43)
Mixed anxiety and
depressive disorder – mild
1 (8) 1 (7)
Mild depressive episode 3 (23) 4 (29)
Moderate depressive episode 0 (0) 3 (21)
Secondary diagnosis category; n (%)
No psychiatric diagnosis
identified
12 (92) 9 (64)
Mixed anxiety and depressive
disorder – mild
1 (8) 1 (7)
Generalised anxiety disorder –
mild
0 (0) 1 (7)
Mixed anxiety and depressive
disorder
0 (0) 2 (14)
Specific (isolated) phobia 0 (0) 1 (7)
Table 2 Participant characteristics at baseline (Continued)
UC, N = 14 EPC, N = 15
Emotional health
PHQ-9; mean (SD) 11.9 (1.8) 14.2 (4.7)
BDI; mean (SD) 12.5 (4.9) 18.4 (7.4)
BAI; mean (SD) 12.5 (4.4) 19.3 (10.7)
Do you believe you have
low mood?; n (%)
Yes 11 (79) 11 (73)
No 3 (21) 4 (27)
Do you want any professional
help for your low mood?; n (%)d
N = 11 N = 11
Strongly prefer help 1 (9) 5 (45)
Prefer help 4 (36) 2 (18)
Prefer not to receive help 3 (27) 3 (27)
Strongly prefer not to
receive help
3 (27) 1 (9)
What type of professional help
would you prefer?; n (%)d
N = 11 N = 11
Strongly prefer non-drug help 6 (55) 9 (82)
Prefer non-drug help 3 (27) 0 (0)
Prefer drug-based help 1 (9) 0 (0)
Strongly prefer drug-based help 0 (0) 0 (0)
Do not mind 1 (9) 2 (18)
Health-related quality of life
EQ-5D-5 L; mean (SD) 0.801 (0.097) 0.644 (0.226)
EQ-5D VAS; mean (SD) 63.0 (23.5) 48.7 (19.3)
HeartQoL; mean (SD) 21.3 (9.1) 15.2 (9.9)
ACS acute coronary syndrome, BAI Beck Anxiety Inventory, BDI-II Beck
Depression Inventory, CIS-R Revised Clinical Interview Schedule, EPC Enhanced
Psychological Care, EQ-5D-5 L EuroQoL Index, IQR interquartile range, PHQ
Patient Health Questionnaire-9, SD standard deviation, UC usual care, VAS
Visual Analogue Scale
aClear diagnostic information was not always present
bIncludes atrial fibrillation, chest pain, heart failure or ischaemic heart disease
cSome participants did not complete this component of the baseline assessment
dOnly completed by participants who believed themselves to have low mood
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baseline score) was 1.7 (95% CI − 3.8 to 7.3; N = 26) at 5
months and 4.4 (95% CI − 1.4 to 10.2; N = 17) at 8
months. Around half of participants with data available
at both baseline and 5 months (N = 26) had a 50% re-
duction in BDI-II at 5 months. A 17% reduction from
baseline symptoms (the MCID) was observed for 10/12
(83%) in EPC and 11/14 (79%) in UC, with 43% (3/7)
and 86% (6/7), respectively, considered to be in remis-
sion (BDI < 14) at 5 months. Among those in remission,
in the EPC arm 2/7 (29%) had a clinically significant and
reliable change, compared with 3/7 (43%) in UC.
In terms of anxiety, the mean difference (EPC minus
UC) in the BAI was 4.6 (95% CI − 0.8 to 10.0) at 5-month
follow-up and 5.0 (95% CI − 1.2 to 11.1) at the 8-month
follow-up.
In terms of HRQL, the mean difference in EQ-5D-5 L
index and Visual Analogue Scale (VAS) scores (adjusted for
baseline score) between EPC and UC at 5-month follow-up
was 0.045 (95% CI − 0.023 to 0.113) and − 0.014 (95% CI −
0.145 to 0.064), respectively. At 8 months the mean differ-
ences were − 0.041 (95% CI − 0.145, 0.064) for the EQ-5D-
5 L index and 1 (95% CI − 17, 19) for the VAS scores, re-
spectively. The mean difference in HeartQoL (adjusted for
baseline score) between EPC and UC at 5-month follow-up
was − 8.2 (95% CI − 14.9 to − 1.4), although by 8 months,
this difference was negligible (0.1, 95% CI − 7.9 to 8.0).
At 5 months, participants in both arms reported a posi-
tive experience of their care on both the CSQ-8 and the
FFT (Table 6), although there was some evidence that in-
dividuals receiving EPC reported higher satisfaction levels.
For example, all the participants in the EPC arm were ex-
tremely satisfied with the amount of help they received
(11/11), and most of the participants in the UC arm were
extremely satisfied (8/13). The majority of participants in
both arms were extremely likely to recommend the service
to friends and family (EPC = 11/13; UC = 10/14).
Calculating the required samples size for a future trial
Assuming an ICC of 0.05, we estimated the sample size in
each of scenarios for a future, definitive cluster RCT based
on the BDI-II MCID observed at the 8-month follow-up
Additional file 1: Table S4). An adequately powered defini-
tive cluster RCT would require 50 cardiac teams and 650
participants (13 participants recruited per team), rando-
mising 25 cardiac teams and 325 participants to each trial
arm. This sample size is large enough to detect an effect
size of 0.35 SD units on the BDI-II with 90% power at the
two-sided 5% level of significance. Consistent with our
pilot data, this calculation assumed 80% follow-up at par-
ticipant level at 8 months. Using pilot data, on average it
took a cardiac team 1.38 months to recruit a participant.
Thus, the length of recruitment for the definitive trial is
estimated to be 18 months (13 × 1.38).
Methods to support economic evaluation
Costing the intervention
The estimated elements of costs, and the cost per par-
ticipant receiving the EPC intervention is presented in
Table 7.
Table 3 Process data for delivery of Enhanced Psychological
Care (EPC) at 8-month follow-up




Number of cardiac rehabilitation
sessions; median (min, max)
Offered 8 (2, 14) 7 (0, 24)
Attended 7.5 (1, 12) 7 (0, 22)
Number of EPC sessions
attended; n (%)





Days elapsed from consent
date to starting cardiac
rehabilitation; median (min, max)
3 (− 15, 27) 5 (− 35, 22)
Participants who started
cardiac rehabilitation prior
to trial recruitment; n/N (%)
6 (43) 2 (13)
Days elapsed from trial entry
to start of EPC; median (min, max)
N/A 5 (0, 19)
Days elapsed from trial entry
to discharge from cardiac
rehabilitation; median (min, max)
69 (13, 112) 89 (48, 185)
Evidence of psychological care
coordination activities provided
in nurse notes; n (%)
N/A 5 (33)
Referral to GP/other psychological
care services; n (%)
0 (0) 7 (47)d
aParticipant had only seven sessions scheduled
bParticipant had eight sessions scheduled but did not attend two sessions
cParticipant had only one session scheduled
dFor some patients, there was no evidence of psychological care coordination
in the nurse notes, but there evidence of onward referral describe in the GP
discharge letter
Table 4 Cardiac events derived from general practitioner (GP)













ACS or revascularisation 2 3 0 1
Other diagnosisb 2 1 1 2
ACS acute coronary syndrome, EPC Enhanced Psychological Care, UC
usual care
aMultiple outcomes can occur in an individual participant
bOther diagnoses recorded include atrial fibrillation, heart failure, ischaemic
coronary disease and left ventricular dysfunction
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The calculation of intervention costs makes no adjust-
ment for the small scale of the pilot trial, and so it is inevit-
ably an overestimate of what the actual cost would be if
the intervention were to be delivered routinely to larger
numbers of patients. For example, here the initial nurse
training costs account for a significant proportion of the
overall cost of providing EPC, and the relative contribution
to the cost per patient will reduce as a larger number of
patients receiving EPC over a longer period. The estimated
time that nurses take to deliver EPC elements within re-
habilitation accounts for a relatively small amount of the
overall cost (£63 of the estimated £959 per participant).
Participants self-reported service use in the time periods
(baseline to 5 months, and 5 months to 8 months). The
types of health service used and associated costs are pre-
sented in the Additional file 1: Table S5. All participants re-
ported using GP services in both periods, and the majority
also had hospital outpatient appointments. Although a mi-
nority had hospital inpatient stays, these account for a large
proportion of the total costs of health care use.
Due to the small sample size, any differences in costs
between the trial arms should not be interpreted, as they
could easily be due to chance. However, these costs could
provide useful point estimates and SDs for planning future
definitive randomised trials of similar interventions in
similar patient groups, as do the data presented previously
on HRQL and EQ-5D-5 L index scores (Table 5).
Sources of data to support economic evaluation
Service-use data for the total 8-month follow-up period
were available from GP records for 27/29 participants and
via self-report for 17/29 participants. For the 17 participants
with data from both sources, we calculated the level of
agreement for the number of GPs or practice nurses visits,
emergency department visits and inpatient hospital admis-
sions (Additional file 1: Table S6). The lowest agreement
was observed for the number of visits to GPs or practice
nurses, with no participants recalling the same number of
GP visits as recorded in GP notes, and only 3/17 (18%) of
participants recalling the same number of practice nurse
visits. In contrast, 11/17 (65%) participants recalled the
same number of emergency department attendances as
their GP records show, and 14/17 (82%) of participants
recalled the same number of hospital inpatient stays. While
the crude agreement was variable for all four types of health
service use there seems to be no systematic tendency to ei-
ther over-estimate or under-estimate service usage. For ex-
ample, while crude agreement between sources was poor
for GP visits, the mean number of GP visits was the same
whether calculated from self-report or GP records data.
Cardiac nurse notes only consistently recorded the use
of hospital services and thus the level of agreement could
only be estimated for the number of hospital admissions
reported by participants and nurse records. The crude
agreement was high (15/17; 88%) between participant re-
ports and nurse records of inpatient stays for the 8-month
follow-up period. The mean (SD) number of self-reported
hospital admissions was 0.5 (0.9) compared with 0.3 (0.6)
as recorded in nurse notes (intraclass correlation coeffi-
cient = 0.55). No participants underestimated the number
of hospital stays, although two individuals overestimated
hospital admissions.
Table 5 Participant-reported mental and physical health outcomes at 5-month and 8-month follow-up
Outcome variable 5 months 8 months
UC, N = 14 EPC, N = 13 Mean difference or
ORa (95% CI)
UC, N = 8 EPC, N = 9 Mean difference or
ORa (95% CI)
BDI-II; mean (SD), n 7.4 (3.7), 14 10.2 (8.4), 12 1.7 (− 3.8, 7.3) 7.0 (3.5), 8 12.6 (6.6), 9 4.4 (− 1.4, 10.2)
50% reduction in BDI-II from
baseline; n/N (%)
7/14 (50) 5/12 (42) 0.71 (0.16, 3.25) 4/8 (50) 2/9 (22) 0.29 (0.04, 2.09)
Remission (< 14 BDI-II) from
baselineb; n/N (%)
6/7 (86) 3/7 (43) 0.13 (0, 1.37) 4/4 (100) 2/5 (40) 0 (0, 1.10)
BDI-II MCID (17.5% reduction
post baseline); n/N (%)
11/14 (79) 10/12 (83) 1.36 (0.22, 8.31) 5/8 (63) 6/9 (67) 1.20 (0.18, 7.99)
BDII-II CSRC from baselinec;
n/N (%)
3/7 (43) 2/7 (29) 0.53 (0.07, 4.33) 2/4 (50) 1/5 (20) 0.25 (0, 3.56)
BAI; mean (SD), n 9.2 (4.0), 14 14.7 (8.3), 13 4.6 (− 0.8, 10.0) 6.4 (4.6), 8 12.7 (7.1), 9 5.0 (− 1.2, 11.1)
EQ-5D-5 L; mean (SD), n 0.875 (0.115), 13 0.885 (0.065), 13 0.045 (− 0.023, 0.113) 0.876 (0.092), 8 0.827 (0.116), 9 − 0.041 (− 0.145, 0.064)
EQ-5D VAS, mean (SD), n 72 (21), 14 72 (21), 12 5 (− 13, 22) 64 (18), 7 64 (12), 8 1 (− 17, 19)
HeartQoL; mean (SD) 31.5 (4.9), 14 22.9 (10.3), 13 − 8.2 (− 14.9, − 1.4) 28.3 (6.7), 8 28.6 (7.6), 9 0.1 (− 7.9, 8.0)
BAI Beck Anxiety Inventory, BDI-II Beck Depression Inventory, CI confidence interval, CSRC clinically significant and reliable change, EPC Enhanced Psychological
Care, EQ-5D L EuroQoL Index, MCID minimally clinical important difference, OR odds ratio, SD standard deviation, UC usual care, VAS Visual Analogue Scale
aBetween-group comparison. The mean difference is adjusted for baseline score. No adjustments for clustering were made
bAt baseline, 7/14 UC participants and 10/15 EPC participants had a BDI-II score ≥ 14; participants with scores ≤ 13 at baseline excluded
cClinically significant and reliable change can only be calculated for participants with a baseline BDI-II score of ≥ 14
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Discussion
In this pilot trial, we successfully tested the methods and
procedures required to undertake a fully powered evalu-
ation of using cardiac rehabilitation nurses to implement
EPC for their patients with new-onset depression. We
Table 6 Patient experience ratings from the Client Satisfaction
Questionnaire (CSQ) and the Friends and Family Test (FFT) at 5-
month follow-up
Patient-reported outcome; n (%) UC, N = 14 EPC, N = 13
Client Satisfaction Questionnaire
How would you rate the quality
of service you have received?
N = 13 N = 11
Excellent 9 (69) 9 (82)
Good 3 (23) 2 (18)
Fair 1 (8) 0 (0)
Poor 0 (0) 0 (0)
Did you get the kind of service
you wanted?a
N = 13 N = 11
Yes, definitely 8 (62) 10 (91)
Yes, generally 5 (38) 1 (9)
To what extent has our
programme met your needs?a
N = 13 N = 11
Almost all of my needs
have been met
9 (69) 9 (82)
Most of my needs
have been met
3 (23) 2 (18)
Only a few of my needs
have been met
1 (8) 0 (0)
If a friend were in need of
similar help, would you
recommend our programme
to him or her?a
N = 14 N = 11
Yes, definitely 9 (64) 11 (100)
Yes, I think so 5 (36) 0 (0)
How satisfied are you with
the amount of help you
have received?a
N = 13 N = 11
Very satisfied 8 (62) 11 (100)
Mostly satisfied 5 (38) 0 (0)
Have the services you received
helped you to deal more
effectively with your problems?a
N = 13 N = 11
Yes, they helped a great deal 8 (62) 9 (82)
Yes, they helped somewhat 5 (38) 2 (18)
In an overall, general sense,
how satisfied are you with the
services you have received?a
N = 13 N = 11
Very satisfied 9 (69) 10 (91)
Mostly satisfied 4 (31) 1 (9)
If you were to seek help again,
would you come back to our
programme?a
N = 13 N = 11
Yes, definitely 7 (54) 10 (91)
Yes, I think so 4 (31) 1 (9)
No, I don’t think so 2 (15) 0 (0)
Table 6 Patient experience ratings from the Client Satisfaction
Questionnaire (CSQ) and the Friends and Family Test (FFT) at 5-
month follow-up (Continued)
Patient-reported outcome; n (%) UC, N = 14 EPC, N = 13
Friends and Family Test
How likely are you to recommend this
help or support to friends and family
if they needed similar care or treatment?a
N = 14 N = 13
Extremely likely 10 (71) 11 (85)
Likely 4 (29) 0 (0)
I did not receive any help or support 0 (0) 2 (15)
EPC Enhanced Psychological Care, UC usual care
aResponses were highly skewed to positive assessments. Unless reported, no
participants used the neutral or negative response categories provided
Table 7 Per patient cost of delivering Enhanced Psychological
Care (EPC)
Unitsd Unit costs £ Cost £
Initial costs
For 15 nurses attending
training (trainers’ and facilitator’s
time, delivery and preparation)
45 + 41 ha Various 7157
Nurse training (nurses’ time) 56 + 21 hc 35b 2695
Nurse manuals (printing) 8 manuals 4 32
Ongoing costs
Telephone clinical supervision
of behavioural activation (BA)
delivery
35 h 50 1750
Nurses’ time for having
supervision (estimated 50 h
overall)
50 h 35b 1750
Total overhead cost of
providing EPC
13,384
Number of participants in
EPC trial arm
15
Mean allocated overhead cost
of EPC per patient (in feasibility
trial)
892
Per participant nurse time for
delivering EPC within cardiac
rehabilitation sessions
1.8 hc 35b 63
Patient booklet print costs 1 4 4
Estimated cost per EPC recipient 959
aTwo figures presented as EPC training was delivered to two different nurse cohorts
bCost per working hour for a Band-5 hospital-based nurse (excluding qualification
costs). Unit Costs of Health and Social Care 2015, PSSRU
cMean of 7.8 rehabilitation sessions attended. First, mid-point and final session 20 min
each; other 4.8 sessions 10 min each = mean of 1 h 48 mins per participant in total
dData sources: trial records (e.g. invoices) or interviews with relevant study
personnel, unless otherwise stated
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recruited eight cardiac rehabilitation nursing teams
drawn from a range of settings in South West England
and the West Midlands, and compared a range of out-
comes against those observed in UC. While the cluster
randomisation process was successfully implemented,
the withdrawal of one randomised team required re-
sponsive action from the research team.
Of 614 patients screened for eligibility over a 6-month
recruitment period, 55 met trial eligibility criteria, of
whom 29 provided baseline data. Follow-up rates at 5-
and 8- months post baseline were 93% and 81%, respect-
ively. A further 21 patients met baseline eligibility cri-
teria, but were not eligible for inclusion on account of
having received pre-existing treatment for depression.
We were unable to recruit patients from ethnic minority
backgrounds. This, and other observed imbalances be-
tween the two trial arms, are likely to be addressed in a
larger, fully powered study.
We successfully collected participant outcome data to
inform key design parameters of a future, definitive trial,
such as recruitment and attrition rates, and participant-
reported outcomes. In addition, we undertook a case note
review of cardiac nurse and GP notes. A review of these
procedures suggested that a future trial might require cap-
ture of data from case note review of cardiology records
for some domains. Collection of BDI-II data proved satis-
factory with only minimal missing data. Although the
number of patients completing the 8-month follow-up
was small, we were able to estimate the distribution of
BDI-II scores, and investigate several approaches to calcu-
late treatment effects for depression status at follow-up.
We were also able to show that an adequately powered
definitive cluster RCT would be challenging. The National
Audit of Cardiac Rehabilitation identified 266 cardiac re-
habilitation teams in England in 2013–2014 [1]. Our sam-
ple size calculations estimated that a definitive RCT
would be required to recruit 50 cardiac teams and 650
participants (recruiting for 18 months) to detect a clinic-
ally meaningful difference in depression severity (BDI-II)
between EPC and UC arms.
In undertaking our economic evaluation, relevant data
were captured with a view to identifying costs across the
whole system of care. Service-use data were collected
from routine and administrative sources, as well as via
participant self-report. We encountered challenges in
identifying time spent by nurses in delivering EPC since
this was distributed across all of the nurse interactions
with the patient rather than in discrete, quantifiable pe-
riods of consultation time. Our study found some evi-
dence to support the use of self-report service-use data,
particularly regarding recall of emergency department
attendance, hospital admission and GP attendance. Al-
though intensive, requiring considerable researcher ef-
fort, our data capture processes appeared satisfactory.
The findings from a nested qualitative study have been
reported elsewhere [29], the core findings of which are
summarised here. Some patients who might have bene-
fitted from EPC did not attend subsequent cardiac re-
habilitation sessions. In addition, some eligible patients
were not offered EPC because of nurse workload. Some
patients chose not to take part in the trial, reporting that
they did not identify themselves as experiencing ‘low
mood’, or did not wish to receive more information relat-
ing to their cardiac event. EPC participants, however,
viewed one-to-one dedicated nurse time addressing psy-
chological issues as important in helping them achieve
timely recovery from their depression. In addition, some
patients identified and valued the holistic approach to
care. Despite this, it was clear that explanation of BA as
a key component of EPC was needed, and that ap-
proaches to delivering the intervention need to be tai-
lored to the needs of the individual.
Qualitative interviews with nurses [29] revealed that
they felt equipped to deliver the EPC intervention, and
valued training in mental health care coordination and
mental health risk assessment, particularly in respect of
the use of the PHQ-9 instrument during their initial
screening appointment. While participating nurses were
generally supportive of the study, it was evident that ac-
commodating EPC within the context of their existing
workload proved extremely challenging and ultimately
unsustainable; this has the potential to undermine the
viability of any future trial.
Strengths and weaknesses
This external pilot study benefitted from a multi-
methods approach, adopted to address clear and pre-
specified research aims. We successfully developed and
delivered an intervention providing EPC to patients who
were depressed following an acute cardiac event, and
who were attending a cardiac rehabilitation programme.
Nested qualitative data found the intervention to be
broadly acceptable to patients, and was welcomed by pa-
tients as reflecting a holistic approach to their care [23,
28, 29]. The intervention was developed by experts in
the field and supported by the development of two man-
uals, targeting nurses and patients. Nurse-participants
welcomed the opportunity of extending their clinical ex-
pertise, particularly in gaining confidence around the
risk assessment of the psychological status of patients at-
tending cardiac rehabilitation.
We successfully recruited cardiac rehabilitation teams
and depressed participants being managed by these
teams to the pilot study, although we were unable to
meet recruitment targets, largely because of nurse-
participant workload limiting nurses’ ability to accom-
modate the intervention within routine care, combined
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with a lower than anticipated rate of eligible and con-
senting patients.
In line with the original commissioning brief, our
intention was to recruit patients who had evidence of
new-onset depression occurring since the cardiac event,
and as a result approximately a quarter of all patients
identified with depressive symptoms during screening
were excluded due to being actively treated for depres-
sion in the previous 6 months. While having an obvious
impact on the sample size available for recruitment, it
also possible that patients with pre-existing depression
might also benefit from improved access to psycho-
logical care in cardiac rehabilitation settings, although
this remains untested in our research.
Selection bias is a known feature of cluster randomised
trials where participants are recruited after clusters have
been randomised and the recruiting clinician is not blind
to the treatment allocation [59]; to explore this, we com-
pared the recruitment rates and participant characteristics
at baseline between the trial arms. Recruitment rates were
broadly comparable, although there was some imbalance
in participant characteristics and outcomes at baseline be-
tween trial arms with EPC arm participants were younger,
from more deprived areas, and with higher depression
scores than UC participants. While these findings may
have arisen by chance due to the small number of clusters
and participants recruited into this pilot trial, the potential
for selection bias remains an important design consider-
ation for a future, definitive trial.
Although we reported effect sizes and associated 95%
CIs for between-group differences in participant-reported
outcomes (including the BDI-II), as this was a pilot study
we did not use analytic methods that allow for clustering
as the number of clusters and participants per cluster were
too small. Our results provided important new data to in-
form future sample size calculations; however, we do not
report p values for the observed effects and the confidence
intervals must be interpreted with caution due to the lack
of adjustment for clustering in the data.
We undertook follow-up of trial participants over a
period of 8 months, and achieved good follow-up rates.
Challenges of delayed recruitment, combined with fund-
ing constraints, meant that a small number of patients
could only be followed up at our primary endpoint (5
months), rather than the full 8 months. Furthermore, we
were unable to recruit patients from ethnic minority
backgrounds, which potentially threatens the external
validity of trial results, although the reasons why we
were unable to do so were not entirely clear.
Substantial challenges were encountered in embedding
supported EPC within routine cardiac rehabilitation,
even when the intervention itself was largely patient-led,
informed by principles of behaviour activation. Thus,
while nurses and patients welcomed the focus on
psychological aspects of care, workload challenges for
cardiac rehabilitation nurses significantly limited the po-
tential to effectively deliver this within the context of
routine cardiac rehabilitation.
Findings in context
In 2012, Leung et al. [6] reported the findings of a meta-
analysis of 22 cohort studies investigating what time-
frame around depression onset was associated with
greater mortality and cardiac morbidity. Estimates of the
prevalence of new-onset depression ranged from 5.5 to
27.9% and recurrent depression from 5.1 to 41.4%. The
pooled analysis identified that both pre-ACS diagnosed
depression and post-ACS diagnosed depression were po-
tentially hazardous. Given this observation, excluding
patients with pre-ACS depression from a future similar
trial may be inappropriate.
The recently reported COBRA trial [64] identified the
potential for effective psychological therapy targeting de-
pression, such as we adopted here, to be delivered without
the need for using costly and highly trained professionals.
Given the key constraint of cardiac nurse workload identi-
fied in our study, embedding psychological practitioners
within cardiac rehabilitation teams might better meet the
mental health needs of such patients.
While the CADENCE study was ongoing, in 2016 Blu-
menthal et al. [65] published a RCT in the US that found
that providing cardiac rehabilitation enhanced by stress
management training delivered by psychological practi-
tioners was associated with significant reductions in
stress and the rate of adverse clinical events when com-
pared with standard cardiac rehabilitation alone. Thus,
although not directly addressing depression, Blumenthal
and colleagues’ study provides further support for the in-
corporation of targeted psychological support for psy-
chologically vulnerable groups of patients in the context
of cardiac rehabilitation.
Implications for future research
While EPC is desirable, embedding our nurse-supported
EPC intervention within routine cardiac rehabilitation
practice is not realistic in the current UK setting. One
alternative might be use dedicated psychological-wellbeing
practitioners, trained in the delivery of low-intensity psy-
chological therapies, to deliver the intervention working
closely with, and preferably embedded within, routine
cardiac rehabilitation services. This change in EPC inter-
vention would require new feasibility testing prior to
undertaking a full-powered trial.
From a trial perspective, we successfully followed up pa-
tients at both 5 and 8 months. However, a future trial
might consider a longer period of follow-up to allow suffi-
cient time to accrue data on clinical events, although this
would add considerably to the cost of a future trial. The
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BDI-II functioned effectively as an outcome for assessing
the severity of depression, although consideration might
be given to precisely which threshold might be imple-
mented to secure a suitable group of patients for a future
fully powered trial. Our data provide the basis for assess-
ment of the size of a future fully powered study. It is likely
that such a study would involve a cluster randomised de-
sign and include patients with pre-existing depression as
well as those new-onset depression following a recent
acute cardiac event. Given the observations reported here,
it is likely that a future study would be considerably larger
in scope; for example, potentially extending across a sub-
stantial proportion of cardiac rehabilitation teams cur-
rently operating in the UK.
Conclusion
Cardiac rehabilitation nurses can be trained to deliver
EPC. While valued by both patients and nurses, organ-
isational and workload constraints are significant bar-
riers to implementation. There remains a need to
develop and test new models of psychological care
within cardiac rehabilitation. This pilot study offers im-
portant data to inform the design and implementation
of future trials of similar interventions to provide psy-
chological care for patients with depression attending
cardiac rehabilitation.
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